Europe • Frankfurt Stock Exchange • FRA:RHK • DE0007042301
The current stock price of RHK.DE is 13.2 EUR. In the past month the price increased by 3.94%. In the past year, price decreased by -9.59%.
ChartMill assigns a technical rating of 7 / 10 to RHK.DE. When comparing the yearly performance of all stocks, RHK.DE is a bad performer in the overall market: 61.69% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to RHK.DE. RHK.DE has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months RHK.DE reported a non-GAAP Earnings per Share(EPS) of 0.57. The EPS decreased by -15.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.28% | ||
| ROA | 2.02% | ||
| ROE | 2.9% | ||
| Debt/Equity | 0.09 |
7 analysts have analysed RHK.DE and the average price target is 14.45 EUR. This implies a price increase of 9.47% is expected in the next year compared to the current price of 13.2.
For the next year, analysts expect an EPS growth of 4.3% and a revenue growth 6.74% for RHK.DE
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 19,041 full-time employees. The firm operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
RHOEN-KLINIKUM AG
Schlossplatz 1
Bad Neustadt an der Saale BAYERN DE
Employees: 14067
Phone: 499771650
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 19,041 full-time employees. The firm operates acute hospitals, medical care centers, and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions, and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
The current stock price of RHK.DE is 13.2 EUR. The price increased by 0.76% in the last trading session.
RHOEN-KLINIKUM AG (RHK.DE) has a dividend yield of 0.76%. The yearly dividend amount is currently 0.
RHK.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RHK.DE.
RHOEN-KLINIKUM AG (RHK.DE) has a market capitalization of 883.87M EUR. This makes RHK.DE a Small Cap stock.
You can find the ownership structure of RHOEN-KLINIKUM AG (RHK.DE) on the Ownership tab.